ELOVL5 and Spinocerebellar ataxia type 38: Accordingly, whether an impact on MUFA metabolism is associated with the role of ELOVL5 mutations in neurodegenerative disorders such as spinocerebellar ataxia 38 (40, 41) remains to be determined.